Thermo Fisher Scientific Inc. Stock
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
559.65 USD | -0.37% | +0.74% | +7.58% |
Jan. 15 | US Government to Restrict Biotechnology Equipment Exports to China | MT |
Jan. 15 | Goldman Sachs Adjusts Thermo Fisher Scientific Price Target to $630 From $655 | MT |
Capitalization | 214B 206B 194B 174B 307B 18,455B 342B 2,361B 875B 7,614B 803B 786B 33,324B | P/E ratio 2024 * |
34.4x | P/E ratio 2025 * | 30.7x |
---|---|---|---|---|---|
Enterprise value | 240B 231B 218B 195B 344B 20,694B 383B 2,648B 981B 8,537B 900B 882B 37,367B | EV / Sales 2024 * |
5.61x | EV / Sales 2025 * | 5.23x |
Free-Float |
86.06% | Yield 2024 * |
0.27% | Yield 2025 * | 0.29% |
Last Transcript: Thermo Fisher Scientific Inc.
1 day | -0.37% | ||
1 week | +0.74% | ||
Current month | +7.58% | ||
1 month | +6.79% | ||
3 months | -6.99% | ||
6 months | +4.73% | ||
Current year | +7.58% |
Director | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 57 | 2009-10-14 |
Director of Finance/CFO | 58 | 2015-07-31 | |
Sebastian Pacios
CTO | Chief Tech/Sci/R&D Officer | - | 2023-09-30 |
Manager | Title | Age | Since |
---|---|---|---|
Scott Sperling
BRD | Director/Board Member | 67 | 2006-11-08 |
Marc Casper
CHM | Chairman | 57 | 2020-02-25 |
Tyler Jacks
BRD | Director/Board Member | 64 | 2009-05-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
11.69% | 0 M€ | -25.75% | ||
7.43% | 30 M€ | +1.14% | - | |
5.37% | 0 M€ | -.--% |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-0.37% | +0.74% | +1.43% | -4.85% | 214B | ||
+1.47% | +9.80% | +58.11% | +102.45% | 211B | ||
-1.46% | -0.63% | +3.16% | -15.76% | 172B | ||
+0.50% | +4.28% | +61.90% | +127.07% | 145B | ||
-0.08% | +2.68% | +0.23% | -15.75% | 60.64B | ||
+1.82% | +3.81% | +12.30% | +5.65% | 42.09B | ||
-0.11% | -1.84% | -6.10% | -39.62% | 41.16B | ||
-0.31% | -0.73% | +14.34% | - | 38.72B | ||
+1.09% | +2.14% | -14.54% | -33.40% | 39.16B | ||
+1.12% | +4.13% | +38.97% | +0.76% | 35.21B | ||
Average | +0.36% | +2.44% | +16.98% | +14.06% | 99.97B | |
Weighted average by Cap. | +0.19% | +3.60% | +23.76% | +34.05% |
2024 * | 2025 * | |
---|---|---|
Net sales | 42.81B 41.16B 38.86B 34.8B 61.3B 3,691B 68.36B 472B 175B 1,523B 161B 157B 6,664B | 44.83B 43.11B 40.7B 36.45B 64.19B 3,865B 71.59B 494B 183B 1,595B 168B 165B 6,979B |
Net income | 6.14B 5.91B 5.58B 4.99B 8.8B 530B 9.81B 67.75B 25.11B 218B 23.04B 22.56B 956B | 6.77B 6.51B 6.14B 5.5B 9.69B 583B 10.8B 74.62B 27.65B 241B 25.37B 24.85B 1,053B |
Net Debt | 25.97B 24.98B 23.58B 21.12B 37.19B 2,239B 41.48B 286B 106B 924B 97.42B 95.41B 4,043B | 20.46B 19.67B 18.57B 16.63B 29.29B 1,763B 32.67B 226B 83.61B 728B 76.72B 75.14B 3,184B |
Date | Price | Change | Volume |
---|---|---|---|
25-01-17 | 559.65 $ | -0.37% | 2,140,069 |
25-01-16 | 561.71 $ | +1.86% | 1,835,537 |
25-01-15 | 551.47 $ | -0.99% | 3,251,325 |
25-01-14 | 556.99 $ | +0.26% | 2,207,392 |
Delayed Quote Nyse, January 17, 2025 at 04:00 pm EST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- TMO Stock